Banner

Pharmaceutical API Manufacturing Global Market Report 2023 – By Therapy Area (Cardiovascular disorders, Metabolic disorders, Neurological disorders, Oncology, Musculoskeletal disorders, NSAIDs, Other therapeutics uses), By API Type (Chemical API, Biological API), By Drug Type (Innovative Drugs, Generic Prescription, Over-the-counter (OTC) Drugs) – Market Size, Trends, And Market Forecast 2023-2032

Starting Price : $5000.00 | Pages : 250 | Published : January 2023 | SKU CODE : h1146 | Delivery Time: 2-3 business days | Format :


Pharmaceutical active pharmaceutical ingredients (API) manufacturing refers to the production of the active substances that give a pharmaceutical medicine its desired impact on the body to treat a condition. Chemical components must be processed in order to make APIs. A biologic drug's active component is referred to as a bulk process intermediate.

The main therapy areas of pharmaceutical API manufacturing are cardiovascular disorders, metabolic disorders, neurological disorders, oncology, musculoskeletal disorders, NSAIDs, and other therapeutics uses. Cardiovascular diseases are a group of heart and blood vessel disorders. The various API type include chemical API and biological API that are used to produce innovative drugs, generic prescription drugs, and over-the-counter (OTC) drugs.

The pharmaceutical active pharmaceutical ingredients (API) manufacturing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical active pharmaceutical ingredients (API) manufacturing market statistics, including pharmaceutical active pharmaceutical ingredients (API) manufacturing industry global market size, regional shares, competitors with a pharmaceutical active pharmaceutical ingredient (API) manufacturing market share, detailed pharmaceutical active pharmaceutical ingredients (API) manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical active pharmaceutical ingredients (API) manufacturing industry. The pharmaceutical active pharmaceutical ingredients (API) manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The global pharmaceutical api manufacturing market grew from $195.29 billion in 2022 to $209.93 billion in 2023 at a compound annual growth rate (CAGR) of 7.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pharmaceutical api manufacturing market is expected to grow from $266.72 billion in 2027 at a CAGR of 6.2%.

The rise in the aging population is one of the major drivers of the pharmaceutical API manufacturing market. As the aging population increases, the demand for pharmaceutical drugs also increases. API acts as a specialty drug in these medicines to cure a particular disease. For instance, in October 2022, according to an article shared by WHO, a Switzerland-based specialized agency of the United Nations responsible for international public health, 80% of senior citizens will reside in low- and middle-income nations by 2050. The population is aging considerably more quickly than in the past. In 2020, there will be more persons over the age of 60 than under five-year-olds. Therefore, rise in aging population is driving the growth of the pharmaceutical API manufacturing market.

Stringent regulations for approval of pharmaceutical drugs act as a restraint on the pharmaceutical API manufacturing market. Various regions have their own set of rules, guidelines, and regulations set by their respective drug regulatory bodies. For example, in Japan, the manufacturers have to register an API with Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) through the country’s Drug Master File (DMF) system. Products like APIs and new excipients i.e. inactive substances used in a drug should be registered compulsorily. The API manufacturer is also responsible for DMF registration, even if they don't have their office in Japan. They should appoint an in-country caretaker (ICC) to apply on their behalf. Also, if there are any changes to be made to DMF products, either an application for change in registration or a minor change notification should be submitted by the ICC to the PMDA. This whole process delays the drug approvals, thereby negatively affecting the pharmaceuticals API manufacturing market.

Many companies use modern technologies such as process control, and powder handling to optimize API manufacturing. These technologies include advances in Lyophilization i.e. freeze-drying process. It is a low-temperature dehydration process that involves freezing the product, lowering pressure, and then removing the ice formed. For instance, Telstar, a company that manufactures efficient integrated systems for pharmaceutical and manufacturing processes, developed LyoGistics Zero, automatic loading and unloading system for freeze dryers to manufacture hazardous products. The system uses a linear magnetic driving mechanism that functions without racks and belts to reduce particle generation and this improves the hygiene in API manufacturing. Also, ILC Dover, a pharmaceutical company, developed the JetBreaker system, a semi-automatic powder handling system that separates powdered media and buffers powders so that they can be mixed better in a solution.

In March 2021, Piramal Pharma Ltd., an India-based healthcare solutions company, acquired Hemmo Pharmaceuticals for an amount of $105.8 million. This acquisition is expected to expand PPS’s capacity to provide integrated services to its clients globally by gaining access to the expanding peptide API industry. The deal would also increase peptide API manufacturing and development capabilities. Hemmo Pharmaceuticals is an India-based developer and manufacturer of peptide APIs.

Major players in the pharmaceutical API manufacturing market are Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim, PfizerInc., Aurobindo Pharma, Novartis AG, Dr. Reddy's Laboratories, Merck & Co.Inc., BASF SE., Bayer Healthcare, Mylan N.V., Albemarle Corporation, Actavis PLC., Hospira Inc., Ranbaxy Laboratories, Virbac, Zoetis, Heska Co., AbbVie Inc., AstraZeneca PLC., Eli Lilly and Company, GlaxoSmithKline PLC., Sanofi, Bristol-Myers Squibb, CiplaInc., and F. Hoffmann-La Roche Ltd.

North America was the largest region in the pharmaceutical API manufacturing market in 2022. The Middle East is expected to be the fastest growing region in the global pharmaceutical API manufacturing market during the forecast period. The regions covered in the global pharmaceutical API manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the pharmaceutical API manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The pharmaceutical active pharmaceutical ingredients (API) manufacturing market includes tablet, capsule, cream, and injectable sales.Values in this market are factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products.

The global pharmaceutical api manufacturing market is segmented -

1) By Therapy Area: Cardiovascular disorders, Metabolic disorders, Neurological disorders, Oncology, Musculoskeletal disorders, NSAIDs, Other therapeutics uses

2) By API Type: Chemical API, Biological API

3) By Drug Type: Innovative Drugs, Generic Prescription, Over-the-counter (OTC) Drugs

    Table Of Contents

    1. Executive Summary

    2. Pharmaceutical API Manufacturing Market Characteristics

    3. Pharmaceutical API Manufacturing Market Trends And Strategies

    4. Pharmaceutical API Manufacturing Market – Macro Economic Scenario

    4.1 COVID-19 Impact On Pharmaceutical API Manufacturing Market

    4.2 Ukraine-Russia War Impact On Pharmaceutical API Manufacturing Market

    4.3 Impact Of High Inflation On Pharmaceutical API Manufacturing Market

    5. Pharmaceutical API Manufacturing Market Size And Growth

    5.1. Global Pharmaceutical API Manufacturing Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Pharmaceutical API Manufacturing Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Pharmaceutical API Manufacturing Market Segmentation

    6.1. Global Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Cardiovascular disorders

    Metabolic disorders

    Neurological disorders

    Oncology

    Musculoskeletal disorders

    NSAIDs

    Other therapeutics uses

    6.2. Global Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Chemical API

    Biological API

    6.3. Global Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Innovative Drugs

    Generic Prescription

    Over-the-counter (OTC) Drugs

    7. Pharmaceutical API Manufacturing Market Regional And Country Analysis

    7.1. Global Pharmaceutical API Manufacturing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Pharmaceutical API Manufacturing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Pharmaceutical API Manufacturing Market

    8.1. Asia-Pacific Pharmaceutical API Manufacturing Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Pharmaceutical API Manufacturing Market

    9.1. China Pharmaceutical API Manufacturing Market Overview

    9.2. China Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Pharmaceutical API Manufacturing Market

    10.1. India Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Pharmaceutical API Manufacturing Market

    11.1. Japan Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Pharmaceutical API Manufacturing Market

    12.1. Australia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Pharmaceutical API Manufacturing Market

    13.1. Indonesia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Pharmaceutical API Manufacturing Market

    14.1. South Korea Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Pharmaceutical API Manufacturing Market

    15.1. Western Europe Pharmaceutical API Manufacturing Market Overview

    15.2. Western Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Pharmaceutical API Manufacturing Market

    16.1. UK Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Pharmaceutical API Manufacturing Market

    17.1. Germany Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Pharmaceutical API Manufacturing Market

    18.4. France Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Pharmaceutical API Manufacturing Market

    19.1. Eastern Europe Pharmaceutical API Manufacturing Market Overview

    19.2. Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Pharmaceutical API Manufacturing Market

    20.1. Russia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Pharmaceutical API Manufacturing Market

    21.1. North America Pharmaceutical API Manufacturing Market Overview

    21.2. North America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Pharmaceutical API Manufacturing Market

    22.1. USA Pharmaceutical API Manufacturing Market Overview

    22.2. USA Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Pharmaceutical API Manufacturing Market

    23.1. South America Pharmaceutical API Manufacturing Market Overview

    23.2. South America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Pharmaceutical API Manufacturing Market

    24.1. Brazil Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Pharmaceutical API Manufacturing Market

    25.1. Middle East Pharmaceutical API Manufacturing Market Overview

    25.2. Middle East Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Pharmaceutical API Manufacturing Market

    26.1. Africa Pharmaceutical API Manufacturing Market Overview

    26.2. Africa Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Pharmaceutical API Manufacturing Market Competitive Landscape And Company Profiles

    27.1. Pharmaceutical API Manufacturing Market Competitive Landscape

    27.2. Pharmaceutical API Manufacturing Market Company Profiles

    27.2.1. Teva Pharmaceutical Industries Ltd.

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Sun Pharmaceutical Industries Ltd.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Boehringer Ingelheim (Germany)

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Pfizer, Inc. (US)

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Aurobindo Pharma

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Pharmaceutical API Manufacturing Pipeline Analysis

    29. Key Mergers And Acquisitions In The Pharmaceutical API Manufacturing Market

    30. Pharmaceutical API Manufacturing Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Historic And Forecast Inflation Rates

    31.4. Research Inquiries

    31.5. The Business Research Company

    31.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Pharmaceutical API Manufacturing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Pharmaceutical API Manufacturing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Table 47: Sun Pharmaceutical Industries Ltd. Financial Performance
  • Table 48: Boehringer Ingelheim (Germany) Financial Performance
  • Table 49: Pfizer, Inc. (US) Financial Performance
  • Table 50: Aurobindo Pharma Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Pharmaceutical API Manufacturing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Pharmaceutical API Manufacturing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Figure 47: Sun Pharmaceutical Industries Ltd. Financial Performance
  • Figure 48: Boehringer Ingelheim (Germany) Financial Performance
  • Figure 49: Pfizer, Inc. (US) Financial Performance
  • Figure 50: Aurobindo Pharma Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report